Hugo R Lara-Martinez: Recognizing HLH After Immune Checkpoint Inhibitor Therapy
Hugo R Lara-Martinez, Former Assistant Professor of Medicine- Hematology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Immunotherapy, adding:
”Excited to share our recently published case series on immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis (HLH).
We highlight the varied clinical presentations, diagnostic challenges, and treatment approaches in this rare but potentially life-threatening hematologic immune-related adverse event.
Grateful to my co-authors for their collaboration.”
Title: Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients
Authors: Mayte G. Martinez-Garza, Effrosyni Apostolidou, Hugo R. Lara-Martinez, Thein H. Oo, Cristhiam M. Rojas-Hernandez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge